ctDNA as a cancer biomarker: A broad overview
Open accessThe DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Abstract
Circulating tumor DNA (ctDNA) in fluids has gained attention because ctDNA seems to identify tumor-specific abnormalities, which could be used for diagnosis, follow-up of treatment, and prognosis: the so-called liquid biopsy. Liquid biopsy is a minimally invasive approach and presents the sum of ctDNA from primary and secondary tumor sites. It has been possible not only to quantify the amount of ctDNA but also to identify (epi)genetic changes. Specific mutations in genes have been identified in the plasma of patients with several types of cancer, which highlights ctDNA as a possible cancer biomarker. However, achieving detectable concentrations of ctDNA in body fluids is not an easy task. ctDNA fragments present a short half-life, and there are no cut-off values to discriminate high and low ctDNA concentrations. Here, we discuss the use of ctDNA as a cancer biomarker, the main methodologies, the inherent difficulties, and the clinical predictive value of ctDNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Savlı, H., Sertdemir, N., Aydın, D., Dursun, B., Kurtaş, Ö., Reka, S., Akkoyunlu, D. S., KESKİN, S. E., Uygun, K., Özden, E., et al. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.05.005 · Cited by 22
Němeček, R., Berkovcová, J., Radová, L., Kazda, T., Mlčochová, J., Vychytilova‐Faltejskova, P., Slabý, O., & Svoboda, M. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s102891 · Cited by 17
Liquid biopsy for predictive mutational profiling of solid cancer: The pathologist’s perspective
Méhes, G. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.04.002 · Cited by 16
Towards Circulating-Tumor DNA-Based Precision Medicine
Hironaka‐Mitsuhashi, A., Calle, A. S., Ochiya, T., Takayama, S., & Suto, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091365 · Cited by 16
Zheng, P., Liang, C., Ren, L., Zhu, D., Feng, Q., Chang, W., He, G., Ye, L., Chen, J., Lin, Q., et al. (2018) · Journal of Oncology · doi:10.1155/2018/5072987 · Cited by 15
Liquid Biopsy Potential Biomarkers in Prostate Cancer
Neuhaus, J., & Yang, B. (2018) · Diagnostics · doi:10.3390/diagnostics8040068 · Cited by 13
Lorber, T., Andor, N., Dietsche, T., Perrina, V., Juškevičius, D., Pereira, K., Greer, S., Krause, A., Müller, D. C., Prince, S. S., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5183 · Cited by 11
The clinical role of ‘liquid biopsy’ in hepatocellular carcinoma
Howell, J. A., & Sharma, R. (2015) · Hepatic Oncology · doi:10.2217/hep.15.38 · Cited by 10
Doval, D. C., Deshpande, R., Dhabhar, B. N., Babu, K., Prabhash, K., Chopra, R., Sripada, P. V., Deshmukh, C. D., & Suryavanshi, M. (2017) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_514_17 · Cited by 10
Thierry, A. R., & Tanos, R. (2018) · médecine/sciences · doi:10.1051/medsci/2018208 · Cited by 8
Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence
Soyano, A. E., Baldeo, C., & Kasi, P. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00046 · Cited by 6
Cited by
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Das, S., Dey, M. K., Devireddy, R., & Gartia, M. R. (2023) · Sensors · doi:10.3390/s24010037 · Cited by 383
Circulating tumour DNA — looking beyond the blood
Tivey, A., Church, M., Rothwell, D., Dive, C., & Cook, N. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00660-y · Cited by 321
Molecular Biomarkers for the Early Detection of Ovarian Cancer
Zhang, R., Siu, M. K. Y., Ngan, H. Y. S., & Chan, K. K. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231912041 · Cited by 283
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
Wang, W., Lian, B., Xu, C., Wang, Q., Li, Z., Zheng, N., Liu, A., Yu, J., Zhong, W., Wang, Z., et al. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100661 · Cited by 14
Metadata
- Authors
- Pessoa, L. S., Heringer, M., & Ferrer, V. P.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 155
- Pages
- 103109
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W3036135178
- Cited by
- 298
- References
- 211
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.